Relationship Between Fat-Soluble Vitamin Supplementation and Blood Concentrations in Adolescent and Adult Patients With Cystic Fibrosis

Overview

Journal Nutr Clin Pract

Publisher Wiley

Specialties Nursing
Nutritional Sciences

Date 2014 Apr 19

PMID 24743047

Citations 12

Authors

Oranan Siwamogsatham

Wei Dong

Jose N Binongo

Ritam Chowdhury

Jessica A Alvarez

Shawna J Feinman

Jessica Enders

Vin Tangpricha

Affiliations

Soon will be listed here.

Abstract

Background: Pancreatic insufficiency is common in patients with cystic fibrosis (CF) and leads to malabsorption of fat-soluble vitamins. Multivitamins, including vitamins A, D, E, and K, are routinely prescribed to patients with CF to prevent vitamin deficiencies. Our objective was to examine the relationship between fat-soluble vitamin supplements and their impact on blood concentrations. Methods: This was a retrospective chart review of patients with CF who were treated at Emory Clinic and Emory University Hospital during 2008-2012. The amount of fat-soluble vitamin supplementation, serum markers of fat-soluble vitamin concentrations, CF transmembrane conductance regulator genotype, and other demographic information were recorded from electronic medical records. Mixed-effects models were used to investigate the trends over time of fat-soluble vitamin supplements and serum vitamin concentrations. Results: In total, 177 charts were eligible. Mean (SD) age was 26.1 (10.2) years. Ninety-two percent of patients had pancreatic insufficiency and 52% had the homozygous ΔF508 mutation. Recorded fat-soluble vitamin supplementation increased in the past 5 years (P < .001 for all). Serum 25-hydroxyvitamin D increased slightly (3% increase; P < .01); however, there were no changes in the blood concentrations of vitamins A, E, and K (P = .26-.96). Conclusions: Despite a near doubling of recorded fat-soluble vitamin supplementation over the past 5 years, there was no parallel increase in blood concentrations of these vitamins. Potential reasons include suboptimal dosages, low adherence, or ongoing issues with malabsorption.

Citing Articles

Vitamin K Status Based on K1, MK-4, MK-7, and Undercarboxylated Prothrombin Levels in Adolescent and Adult Patients with Cystic Fibrosis: A Cross-Sectional Study.

Krzyzanowska-Jankowska P, Nowak J, Karazniewicz-Lada M, Jamka M, Klapkova E, Kurek S Nutrients. 2024; 16(9).

PMID: 38732584 PMC: 11085146. DOI: 10.3390/nu16091337.

Serum leptin and neuropeptide Y in patients with cystic fibrosis-A single center study.

Galiniak S, Podgorski R, Rachel M, Mazur A Front Med (Lausanne). 2022; 9:959584.

PMID: 36186778 PMC: 9515389. DOI: 10.3389/fmed.2022.959584.

Update on the management of vitamins and minerals in cystic fibrosis.

Sankararaman S, Hendrix S, Schindler T Nutr Clin Pract. 2022; 37(5):1074-1087.

PMID: 35997322 PMC: 9544449. DOI: 10.1002/ncp.10899.

CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis.

Sommerburg O, Hammerling S, Schneider S, Okun J, Langhans C, Leutz-Schmidt P Antioxidants (Basel). 2021; 10(3).

PMID: 33808590 PMC: 8003491. DOI: 10.3390/antiox10030483.

Copper and Copper/Zinc Ratio in a Series of Cystic Fibrosis Patients.

Escobedo-Monge M, Barrado E, Alonso Vicente C, Escobedo-Monge M, Torres-Hinojal M, Marugan-Miguelsanz J Nutrients. 2020; 12(11).

PMID: 33143143 PMC: 7692365. DOI: 10.3390/nu12113344.

References

Ramsey B, Farrell P, Pencharz P . Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee. Am J Clin Nutr. 1992; 55(1):108-16. DOI: 10.1093/ajcn/55.1.108. View

Kalivianakis M, Minich D, Bijleveld C, van Aalderen W, Stellaard F, Laseur M . Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr. 1999; 69(1):127-34. DOI: 10.1093/ajcn/69.1.127. View

Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman H . Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros. 2004; 1(2):51-75. DOI: 10.1016/s1569-1993(02)00032-2. View

Solomons N, Wagonfeld J, Rieger C, Jacob R, Bolt M, HORST J . Some biochemical indices of nutrition in treated cystic fibrosis patients. Am J Clin Nutr. 1981; 34(4):462-74. DOI: 10.1093/ajcn/34.4.462. View

Bines J, Truby H, Armstrong D, Carzino R, Grimwood K . Vitamin A and E deficiency and lung disease in infants with cystic fibrosis. J Paediatr Child Health. 2006; 41(12):663-8. DOI: 10.1111/j.1440-1754.2005.00755.x. View

Congden P, Bruce G, Rothburn M, Clarke P, Littlewood J, Kelleher J . Vitamin status in treated patients with cystic fibrosis. Arch Dis Child. 1981; 56(9):708-14. PMC: 1627301. DOI: 10.1136/adc.56.9.708. View

Kalnins D, Wilschanski M . Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies. Drug Des Devel Ther. 2012; 6:151-61. PMC: 3392141. DOI: 10.2147/DDDT.S9258. View

Kerem E, Corey M, Kerem B, Rommens J, Markiewicz D, Levison H . The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med. 1990; 323(22):1517-22. DOI: 10.1056/NEJM199011293232203. View

Conway S, Wolfe S, Brownlee K, White H, Oldroyd B, Truscott J . Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics. 2005; 115(5):1325-31. DOI: 10.1542/peds.2004-1242. View

10.

Sokol R, Reardon M, Accurso F, Stall C, Narkewicz M, Abman S . Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr. 1989; 50(5):1064-71. DOI: 10.1093/ajcn/50.5.1064. View

11.

McKone E, Emerson S, Edwards K, Aitken M . Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet. 2003; 361(9370):1671-6. DOI: 10.1016/S0140-6736(03)13368-5. View

12.

Sitrin M, Lieberman F, JENSEN W, Noronha A, Milburn C, Addington W . Vitamin E deficiency and neurologic disease in adults with cystic fibrosis. Ann Intern Med. 1987; 107(1):51-4. DOI: 10.7326/0003-4819-107-1-51. View

13.

Grossmann R, Zughaier S, Liu S, Lyles R, Tangpricha V . Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr. 2012; 66(9):1072-4. PMC: 3638806. DOI: 10.1038/ejcn.2012.82. View

14.

Maqbool A, Stallings V . Update on fat-soluble vitamins in cystic fibrosis. Curr Opin Pulm Med. 2008; 14(6):574-81. DOI: 10.1097/MCP.0b013e3283136787. View

15.

Couper R, Corey M, Moore D, Fisher L, FORSTNER G, Durie P . Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency. Pediatr Res. 1992; 32(2):179-82. DOI: 10.1203/00006450-199208000-00011. View

16.

Obeid M, Price J, Sun L, Scantlebury M, Overby P, Sidhu R . Facial palsy and idiopathic intracranial hypertension in twins with cystic fibrosis and hypovitaminosis A. Pediatr Neurol. 2011; 44(2):150-2. DOI: 10.1016/j.pediatrneurol.2010.10.002. View

17.

Wolfenden L, Judd S, Shah R, Sanyal R, Ziegler T, Tangpricha V . Vitamin D and bone health in adults with cystic fibrosis. Clin Endocrinol (Oxf). 2008; 69(3):374-81. PMC: 2851223. DOI: 10.1111/j.1365-2265.2008.03216.x. View

18.

Feranchak A, Sontag M, Wagener J, Hammond K, Accurso F, Sokol R . Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr. 1999; 135(5):601-10. DOI: 10.1016/s0022-3476(99)70059-4. View

19.

Stallings V, Stark L, Robinson K, Feranchak A, Quinton H . Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008; 108(5):832-9. DOI: 10.1016/j.jada.2008.02.020. View

20.

Aird F, Greene S, Ogston S, MacDonald T, Mukhopadhyay S . Vitamin A and lung function in CF. J Cyst Fibros. 2006; 5(2):129-31. DOI: 10.1016/j.jcf.2005.11.007. View